We currently allow a patient to have their type and screen (or crossmatch) drawn within 30 days of their scheduled surgery if they haven't been pregnant or transfused within the past 3 months (and verify this information upon admission). I was thinking of changing that to only allowing them to come in within 3 days of surgery but it's not very "patient-centric". Thoughts on the goods and bads of extending these pre-op samples....
So I was wondering if anyone else could chime in on this.
I have a few different scenarios, so if it wouldn't be to much to ask, please specify which one is being responded to.
A.) If a patient comes in for pre-op labs to be done; how is the patient re-identified/verified when they come back the next day for admission?
B.) A patient comes in for same-day surgery with blood on hold for OR; the patient is discharged that evening. The patient comes back in 2 days and the MD is requesting RBCs (still within 72 hr acceptability) Is the original sample still valid, or is a new sample required?
C.) How is patient ID verified for patients that have multiple reoccurring transfusions on an outpatient basis?
Hello Blood Bankers...
Our facility is currently validating electronic crossmatching and I have a question...
The AABB guideline for implementing an electronic crossmatch suggests having two separate sources of ABO/Rh anti-sera for testing the ABO/Rh. The second blood types should be from a separately collected specimen.
Our facility currently draws a second specimen if the patient does not have a blood type on file in our Blood Bank. Is testing the initial and 2nd specimen with two different anti-sera's really necessary?
Thanks in advance for your input.